FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)

View source ↗

Summary

FDA approved a supplemental application for Naproxen Sodium from CVS under ANDA 091353, resulting in updated approval for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Gout
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Naproxen sodium (naproxen sodium)

Snippet

SUPPL AP for NAPROXEN SODIUM (NAPROXEN SODIUM)